Burning Rock Biotech Ltd business relationships

Companies named in Burning Rock Biotech Ltd’s 20-F filed 2026-04-28, and public companies whose annual reports name Burning Rock Biotech Ltd. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.

Open on the map Full AI visibility profile

AEO visibility: 5.4 / 10
AI naming: 72 / 100
Agent readiness: 0 / 100
AI adoption: 0 / 100

Named in Burning Rock Biotech Ltd’s annual report 3

ASTRAZENECA PLC (AZN)Customer7.7
“Our OncoScreen ™ Plus was also featured in a phase 3 multi-regional clinical trial sponsored by AstraZeneca, one of our pharma clients.” SEC filing
Merck & Co., Inc. (MRK)Partner7.7
“Our OncoCompass ™ Target was selected in our companion diagnostics ("CDx") collaboration with Merck for the MET inhibitor tepotinib for the China market.” SEC filing
TARGET CORP (TGT)Partner6.7
“Our OncoCompass ™ Target was selected in our companion diagnostics ("CDx") collaboration with Merck for the MET inhibitor tepotinib for the China market.” SEC filing

Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.